About GLYCOMANTRA INC
Glycomantra is a biologics company developing novel therapeutics for unmet medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes. The company has received $6 million in federal funding so far.
Development of novel therapeutics for unmet medical needsResearch in translational glycobiologyDevelopment of carbohydrate-based therapeutics for cancer, fibrosis, and diabetesProtein or antibody purification services
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GLYCOMANTRA INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.